These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35597071)

  • 61. Value of Nonrigid Registration of Pre-Procedure MR with Post-Procedure CT After Radiofrequency Ablation for Hepatocellular Carcinoma.
    Park J; Lee JM; Lee DH; Joo I; Yoon JH; Park JY; Klotz E
    Cardiovasc Intervent Radiol; 2017 Jun; 40(6):873-883. PubMed ID: 28091728
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Stereotactic Microwave Ablation of Hepatocellular Carcinoma: The Impact of Tumor Size and Minimal Ablative Margin on Therapeutic Success.
    Pausch AM; Ghali T; Wertheimer T; Zeman F; Mueller K; Doppler MC; Einspieler I; Beyer LP; Schleder S; Stroszczynski C; Luerken L
    Tomography; 2022 Dec; 9(1):50-59. PubMed ID: 36648992
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunotherapy response evaluation with magnetic resonance elastography (MRE) in advanced HCC.
    Qayyum A; Hwang KP; Stafford J; Verma A; Maru DM; Sandesh S; Sun J; Pestana RC; Avritscher R; Hassan MM; Amin H; Rashid A; Wistuba II; Ehman RL; Ma J; Kaseb AO
    J Immunother Cancer; 2019 Nov; 7(1):329. PubMed ID: 31779702
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma: A propensity score matching analysis.
    Shuanggang C; Shen L; Qiu Z; Qi H; Cao F; Xie L; Fan W
    J Cancer Res Ther; 2020; 16(2):250-257. PubMed ID: 32474509
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 3.0-T closed MR-guided microwave ablation for HCC located under the hepatic dome: a single-center experience.
    Xu K; Li Z; Wang C; Tian C; Jiao D; Han X; Yan Y
    Int J Hyperthermia; 2022 Dec; 39(1):1044-1051. PubMed ID: 35940593
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Use of magnetic resonance elastography for assessing liver functional reserve: A clinical study.
    Li B; Min J; Liang WR; Zhang GQ; Wu JJ; Jin K; Huang W; Ying CY; Chao M
    World J Gastroenterol; 2015 Jun; 21(24):7522-8. PubMed ID: 26139999
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of the efficacy and postoperative outcomes of hydrodissection-assisted microwave ablation for subcapsular hepatocellular carcinoma and colorectal liver metastases.
    Liu C; He J; Li T; Hong D; Su H; Shao H
    Abdom Radiol (NY); 2021 May; 46(5):2161-2172. PubMed ID: 33108496
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Liver tumor ablation in difficult locations: Microwave ablation of perivascular and subdiaphragmatic hepatocellular carcinoma.
    Makovich Z; Logemann J; Chen L; Mhaskar R; Choi J; Parikh N; El-Haddad G; Kis B
    Clin Imaging; 2021 Mar; 71():170-177. PubMed ID: 33285405
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rhein-based necrosis-avid MRI contrast agents for early evaluation of tumor response to microwave ablation therapy.
    Wu T; Zhang J; Jin Q; Gao M; Zhang D; Zhang L; Feng Y; Ni Y; Yin Z
    Magn Reson Med; 2019 Dec; 82(6):2212-2224. PubMed ID: 31418484
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Early assessment of coagulation necrosis after hepatic microwave ablation: a comparison of non-enhanced and enhanced T1-weighted images.
    Jia ZY; Chen QF; Yang ZQ; Wu WT; Shi HB; Liu S
    Abdom Radiol (NY); 2017 Jun; 42(6):1781-1787. PubMed ID: 28180923
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The effect of MWA protocols upon morphology and IVIM parameters of hepatic ablation zones-a preliminary in vivo animal study with an MRI-compatible microwave ablation device.
    Ye W; Yang W; Guo C; Dong C; Shi F; Liang C
    Diagn Interv Radiol; 2022 Mar; 28(2):115-123. PubMed ID: 35548895
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone.
    Smolock AR; Cristescu MM; Hinshaw A; Woo KM; Wells SA; Ziemlewicz TJ; Lubner MG; Dalvie PS; Louis Hinshaw J; Brace CL; Ozkan OS; Lee FT; Laeseke P
    Abdom Radiol (NY); 2018 Sep; 43(9):2497-2504. PubMed ID: 29450606
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of Medium-Term Efficacy of Y90 Radiation Segmentectomy vs Percutaneous Microwave Ablation in Patients with Solitary Surgically Unresectable < 4 cm Hepatocellular Carcinoma: A Propensity Score Matched Study.
    Arndt L; Villalobos A; Wagstaff W; Cheng B; Xing M; Ermentrout RM; Bercu Z; Cristescu M; Shah A; Wedd J; Majdalany BS; Magliocca JF; Sellers MT; Kokabi N
    Cardiovasc Intervent Radiol; 2021 Mar; 44(3):401-413. PubMed ID: 33230652
    [TBL] [Abstract][Full Text] [Related]  

  • 74. New microwave ablation system for unresectable liver tumors that forms large, spherical ablation zones.
    Imajo K; Tomeno W; Kanezaki M; Honda Y; Kessoku T; Ogawa Y; Yoshida K; Yoneda M; Kirikoshi H; Ono M; Kaneta T; Inoue T; Teratani T; Saito S; Nakajima A
    J Gastroenterol Hepatol; 2018 Dec; 33(12):2007-2014. PubMed ID: 29851164
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MR elastography of liver tumors: preliminary results.
    Venkatesh SK; Yin M; Glockner JF; Takahashi N; Araoz PA; Talwalkar JA; Ehman RL
    AJR Am J Roentgenol; 2008 Jun; 190(6):1534-40. PubMed ID: 18492904
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of the MR and pathology characteristics immediately following percutaneous MR-guided microwave ablation in a rabbit kidney VX2 tumor implantation model.
    Li H; Lin Z; Chen J; Guo R
    Int J Hyperthermia; 2019; 36(1):1197-1206. PubMed ID: 31814458
    [No Abstract]   [Full Text] [Related]  

  • 77. Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selection.
    Chong CCN; Lee KF; Chu CM; Chan AWH; Wong J; Chan SL; Lok HT; Fung AKY; Fong AKW; Cheung YS; Yu SCH; Johnson P; Lai PBS
    HPB (Oxford); 2018 Jun; 20(6):546-554. PubMed ID: 29352659
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Percutaneous US-guided MWA of small liver HCC: predictors of outcome and risk factors for complications from a single center experience.
    Biondetti P; Fumarola EM; Ierardi AM; Coppola A; Gorga G; Maggi L; Valconi E; Angileri SA; Carrafiello G
    Med Oncol; 2020 Apr; 37(5):39. PubMed ID: 32239295
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MR-guided microwave ablation in hepatic tumours: initial results in clinical routine.
    Hoffmann R; Rempp H; Keßler DE; Weiß J; Pereira PL; Nikolaou K; Clasen S
    Eur Radiol; 2017 Apr; 27(4):1467-1476. PubMed ID: 27553935
    [TBL] [Abstract][Full Text] [Related]  

  • 80. New approach for hepatocellular carcinoma treatment.
    Tabacelia D; Stroescu C; Dumitru R; Grigorescu RR; Martiniuc A; Husar-Sburlan IA; Copca N
    J Med Life; 2022 Jan; 15(1):138-143. PubMed ID: 35186148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.